SOX2 Plays a Critical Role in the Pituitary, Forebrain, and Eye during Human Embryonic Development
Open Access
- 1 May 2008
- journal article
- case report
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 93 (5), 1865-1873
- https://doi.org/10.1210/jc.2007-2337
Abstract
Context: Heterozygous, de novo mutations in the transcription factor SOX2 are associated with bilateral anophthalmia or severe microphthalmia and hypopituitarism. Variable additional abnormalities include defects of the corpus callosum and hippocampus. Objective: We have ascertained a further three patients with severe eye defects and pituitary abnormalities who were screened for mutations in SOX2. To provide further evidence of a direct role for SOX2 in hypothalamo-pituitary development, we have studied the expression of the gene in human embryonic tissues. Results: All three patients harbored heterozygous SOX2 mutations: a deletion encompassing the entire gene, an intragenic deletion (c.70_89del), and a novel nonsense mutation (p.Q61X) within the DNA binding domain that results in impaired transactivation. We also show that human SOX2 can inhibit β-catenin-driven reporter gene expression in vitro, whereas mutant SOX2 proteins are unable to repress efficiently this activity. Furthermore, we show that SOX2 is expressed throughout the human brain, including the developing hypothalamus, as well as Rathke’s pouch, the developing anterior pituitary, and the eye. Conclusions: Patients with SOX2 mutations often manifest the unusual phenotype of hypogonadotropic hypogonadism, with sparing of other pituitary hormones despite anterior pituitary hypoplasia. SOX2 expression patterns in human embryonic development support a direct involvement of the protein during development of tissues affected in these individuals. Given the critical role of Wnt-signaling in the development of most of these tissues, our data suggest that a failure to repress the Wnt-β-catenin pathway could be one of the underlying pathogenic mechanisms associated with loss-of-function mutations in SOX2.Keywords
This publication has 33 references indexed in Scilit:
- SOX2 anophthalmia syndrome: 12 new cases demonstrating broader phenotype and high frequency of large gene deletionsBritish Journal of Ophthalmology, 2007
- Lack of the murine homeobox geneHesx1leads to a posterior transformation of the anterior forebrainDevelopment, 2007
- Hypogonadotropic hypogonadism in an adult female with a heterozygous hypomorphic mutation of SOX2Acta Endocrinologica, 2007
- Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humansJCI Insight, 2006
- SOX2 is a dose-dependent regulator of retinal neural progenitor competenceGenes & Development, 2006
- Homeodomain-Mediated β-Catenin-Dependent Switching Events Dictate Cell-Lineage DeterminationCell, 2006
- Bilateral anophthalmia and brain malformations caused by a 20‐bp deletion in the SOX2 geneClinical Genetics, 2005
- SOX2 anophthalmia syndromeAmerican Journal of Medical Genetics Part A, 2005
- Delineation of an estimated 6.7 MB candidate interval for an anophthalmia gene at 3q26.33-q28 and description of the syndrome associated with visible chromosome deletions of this regionEuropean Journal of Human Genetics, 2002
- Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon CarcinomaScience, 1997